Abbelight key facts
as of Oct 2026- Developer of a modular product technology designed to provide single-molecule localization microscopy to researchers.
- Abbelight is valued at approximately $12.4M as of Oct 2026 (last reported valuation).
- It has raised $5.9M; the latest was Later Stage VC in Jan 2026.
- Notable investors include European Innovation Council, Agoranov, General Inception, Odyssee Venture, Avant Bio — 9 tracked in total.
- Status: Privately Held (backing).
Abbelight's last reported valuation, Mar 2023. Nothing priced has surfaced since.
- ·Watch Abbelight: the Monday email on marks, rounds and moves
Abbelight funding rounds
No funding rounds for Abbelight are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Abbelight valuation
Abbelight's last reported valuation was $12.4 million in Mar 2023. No priced round, secondary trade or fund mark has surfaced since.
Abbelight investors
9 investors are on record for Abbelight, including European Innovation Council, Agoranov, General Inception and Odyssee Venture.
About Abbelight
Developer of a modular product technology designed to provide single-molecule localization microscopy to researchers. The company's technology offers single-molecule localization microscopy that is a combination of consumable, hardware, and software techniques to achieve reliable state-of-the-art science, enabling companies conducting research in the fields of biology, pharmacology, and environment to implement super-resolved fluorescence microscopy approaches to observe biological samples with improved resolution.
- Sector
- Information Technology
- HQ
- Cachan, France
- Founded
- 2016
- Employees
- 60
- Website
- abbelight.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.